Table 2.
Dichotomized clinical and safety endpoints for first-pass vs. multiple-pass final TICI scores.
| Final 2b, FP 2b | Final 2b, not FP 2b | P-value | Final 2c, FP 2c | Final 2c, not FP 2c | P-value | Final 3, FP 3 | Final 3, not FP 3 | P-value | |
|---|---|---|---|---|---|---|---|---|---|
| 90-day mRS0–2 | 9/12 (75%) | 7/15 (46.7%) | 0.24 | 15/17 (88.2%) | 14/23 (60.9%) | 0.08 | 33/42 (78.6%) | 20/35 (57.1%) | 0.04 |
| 90-day mRS0–1 | 8/12 (66.7%) | 3/15 (20%) | 0.02 | 12/17 (70.6%) | 8/23 (34.8%) | 0.03 | 28/42 (66.7%) | 17/35 (48.6%) | 0.11 |
| 24-hr NIHSS drop 8+ pts | 8/13 (61.5%) | 6/15 (40%) | 0.26 | 14/18 (77.8%) | 12/24 (50%) | 0.07 | 29/40 (72.5%) | 21/34 (61.8%) | 0.33 |
| sICH | 0/13 | 2/15 (13.3%) | 0.48 | 0/18 | 3/24 (12.5%) | 0.25 | 1/44 (2.3%) | 1/35 (2.9%) | 1.00 |
| 90-daymortality | 0/12 | 0/15 | NC | 0/17 | 3/23 (13.0%) | 0.25 | 3/42 (7.1%) | 6/35 (17.1%) | 0.17 |
FP, first-pass; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; NC, not calculable; TICI, Treatment in Cerebral Ischemia scale.